Biological enzymatic inhibitors

Kinetics is the branch of science concerned with the rates of chemical reactions. The study of enzyme kinetics addresses the biological roles of enzymatic catalysts and how they accomplish their remarkable feats. In enzyme kinetics, we seek to determine the maximum reaction velocity that the enzyme can attain and its binding affinities for substrates and inhibitors. Coupled with studies on the structure and chemistry of the enzyme, analysis of the enzymatic rate under different reaction conditions yields insights regarding the enzyme s mechanism of catalytic action. Such information is essential to an overall understanding of metabolism. 

Abstract The entry of viruses into target cells involves a complex series of sequential steps, with opportunities for inhibition at every stage. Entry inhibitors exert their biological properties by inhibiting protein-protein interactions either within the viral envelope (Env) glycoproteins or between viral Env and host-cell receptors. The nature of resistance to entry inhibitors also differs from compounds inhibiting enzymatic targets due to their different modes of action and the relative variability in... 

Weissbach, H. and Brot, N. (1981). Enzymatic reduction of oxidised alpha-l-proteinase inhibitor restores biological activity. Proc. Natl Acad. Sci. USA, 78, 7483—7486. 

However, there are two problems with these unconjugated lactones lack of selectivity and limited stability of the inhibitor in biological buffers. Coumarin carboxylates have been developed to improve selectivity toward a given serine protease (Section 11.4.1). On the other hand, the amide bond is chemically and enzymatically much more stable than the ester one. This raised the question of whether a starting functionalized lactam behaved like the previous lactones and generated in situ a quinonimine methide, the aza-analogue of the quinone methide (Section 11.5). 

In this section, we present some recent applications of DFT to the study of enzymatic reactions of pharmaceutical interest. One of the major aims of these studies was to identify TS features that, because the biological targets investigated are involved in the pathogenesis of diseases, could be exploited when designing inhibitors of these enzymes. 

Rare or unnatural monosaccharides have many useful applications as nonnutritive sweeteners, glycosidase inhibitors and so on. For example, L-glucose and L-fructose are known to be low-calorie sweeteners. In addition, rare or unnatural monosaccharides are potentially useful as chiral building blocks for the synthesis of biologically active compounds. Therefore, these compounds have been important targets for the development of enzymatic synthesis based in the use of DHAP-dependent aldolases alone or in combination with isomerases. Fessner et al. showed that rare ketose-1-phosphates could be reached not only by aldol addition catalyzed by DHAP-dependent aldolases, but by enzymatic isomerization/ phosphorylation of aldoses [35]. Thus, for example, L-fructose can be prepared... 

Y. Zhang, Inhibitors targeting the enzymatic activity and biological function of Pini, Mini Rev. Org. Chem. 1 (2004) 359-366. 

---